Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | PRKCA | P17252 | 1/20 | 0.31 |
| ▸ | SCN1A | P35498 | 1/20 | 0.31 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.31 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27255639 | 0.92 | MEN1 (0.31) | ALDH1A1MEN1KMT2AATMPRKCA | |
| SCHEMBL27255640 | 0.92 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1POLBTSHRNPSR1 | |
| SCHEMBL19601035 | 0.83 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AATML3MBTL1 | |
| SCHEMBL27255646 | 0.83 | ALDH1A1 (0.34) | ALDH1A1MEN1KMT2AATMPOLB | |
| SCHEMBL25454578 | 0.82 | MEN1 (0.31) | ALDH1A1MEN1KMT2AATMPOLB | |
| SCHEMBL25454582 | 0.82 | MEN1 (0.33) | ALDH1A1MEN1KMT2AATMPOLB | |
| SCHEMBL19601039 | 0.79 | ALDH1A1 (0.36) | ALDH1A1MEN1KMT2AATML3MBTL1 | |
| SCHEMBL19601631 | 0.78 | MEN1 (0.37) | ALDH1A1MEN1KMT2AATML3MBTL1 | |
| SCHEMBL27255643 | 0.77 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1POLBTSHRNPSR1 | |
| SCHEMBL25596679 | 0.77 | ALDH1A1 (0.36) | ALDH1A1MEN1KMT2AATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240210824-A1 | CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240210824-A1 | CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SCO2, CBR1, OXGR1 | ALDH1A1 492/4885MEN1 2790/4885KMT2A 2023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.